Internal Medicine · Summit, NJ
NPI
1629231279
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1 Springfield Ave, Suite 1a
Summit, NJ, 07901
Phone (908) 273-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
2,154 services
Medicare patients, 2024
849
Average age 73
Drug cost, 2024
$2.6M
6,416 prescriptions
Company payments, 2025
$1,175
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Huberman was code 99214 (office e&m - established), 1,454 times for 803 patients. In total Daniel Huberman billed 2,154 services in 13 codes, and Medicare paid $154K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,454 | 803 | $86.38 | $126K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 519 | 410 | $12.39 | $6,432 |
| 99205 Office E&M - New | Office | 65 | 65 | $167.05 | $11K |
| 99215 Office E&M - Established | Office | 61 | 44 | $142.35 | $8,683 |
| 95251 Test - Miscellaneous | Office | 21 | 17 | $25.42 | $534 |
| 99213 Office E&M - Established | Office | 15 | 14 | $45.89 | $688 |
By year: 2022 $174K for 1,605 services; 2023 $153K for 1,527 services; 2024 $154K for 2,154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Huberman prescribed most often to Medicare patients was Levothyroxine Sodium, with 636 prescriptions and refills. In total Daniel Huberman wrote 6,416 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 636 | 1,608 | 158 | $7,519 |
| Ozempic Semaglutide | 563 | 761 | 100 | $690K |
| Metformin Hcl Er Metformin Hcl | 466 | 1,210 | 132 | $6,695 |
| Synthroid Levothyroxine Sodium | 376 | 1,008 | 94 | $34K |
| Mounjaro Tirzepatide | 348 | 440 | 59 | $448K |
| Jardiance Empagliflozin | 261 | 411 | 51 | $232K |
| Glimepiride Generic | 251 | 658 | 65 | $4,029 |
| Metformin Hcl Generic | 225 | 559 | 58 | $2,025 |
| Farxiga Dapagliflozin Propanediol | 213 | 335 | 37 | $178K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 199 | 423 | 56 | $34K |
| Atorvastatin Calcium Generic | 188 | 513 | 52 | $2,116 |
| Alendronate Sodium Generic | 161 | 395 | 53 | $1,410 |
| Rosuvastatin Calcium Generic | 149 | 405 | 45 | $1,844 |
| Repaglinide Generic | 148 | 340 | 40 | $7,290 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 123 | 343 | 47 | $13K |
Brand drugs: 3,254 claims; generic drugs: 2,894 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Huberman $1,175 ($1,175 in general payments such as food, travel and fees) from 29 companies. The largest payer was Amgen Inc. with $181.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 15 | $181 |
| Lilly USA, LLC LLY | 11 | $133 |
| Xeris Pharmaceuticals, Inc. | 4 | $72.67 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $61.71 |
| Dexcom, Inc. DXCM | 2 | $60.65 |
| Mannkind Corporation MNKD | 2 | $57.72 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $54.3 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $52.47 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $52.31 |
| Novo Nordisk Inc NVO | 2 | $47.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.